In a move that signals its growing ambition in the healthcare space, Havas has announced a strategic investment and partnership with Ostro, the AI-driven engagement platform built for the life sciences industry.
As healthcare brands face increasing pressure to connect meaningfully with both healthcare professionals (HCPs) and patients, Ostro offers a compelling solution. Its AI platform personalizes healthcare journeys, helping life science companies create smarter, more compliant digital interactions—driving better patient outcomes and stronger brand impact.
Interestingly, what sets Ostro apart is its seamless integration across branded and unbranded platforms, enabling dynamic, AI-powered engagement that meets stringent regulatory standards—all within eight weeks.
“At Havas, we’re always seeking technologies that deliver real value to our clients,” said Yannick Bolloré, CEO and Chairman, Havas. “Ostro’s innovative approach fits perfectly into our Converged strategy, and it’s a key part of our €400 million investment commitment into data, technology, and AI.”
The collaboration will initially empower clients within the Havas Health Network, with a vision to expand across Havas Creative and Media Networks. This partnership aims to unlock deeper customer insights, speed up content delivery, and improve omnichannel strategies through Ostro’s cutting-edge technology.
Donna Murphy, Global CEO of Havas Health & Creative Networks, shared, “Creativity and intelligence must go hand-in-hand today. Partnering with Ostro allows us to help our clients offer more personalized, compliant, and emotionally relevant healthcare experiences.”
Meanwhile, Ostro’s expansion into medical affairs and other healthcare verticals signals further innovation ahead.
Dr. Chase Feiger, CEO and Co-Founder of Ostro, added, “Our vision has always been simple — to make healthcare engagement intuitive and deeply personal. Partnering with a global force like Havas gives us the right platform to scale that mission.”
Echoing this, Ahmed Elsayyad, President and Co-Founder of Ostro, noted,
“Ostro’s strength lies in context-aware, real-time engagement. It’s about dynamic storytelling that fits each step of the healthcare journey, not generic messaging.”
The investment, advised by Houlihan Lokey, further strengthens Havas’ long-term pivot towards AI, data, and intelligent content — promising a smarter, faster, and more human-centered future for healthcare marketing.
